TUMOUR CELL MOBILISATION

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting TUMOUR CELL MOBILISATION:

# Drug Count
0 TACROLIMUS 4
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 4
2 TACROLIMUS OINTMENT 0.1% 4
3 AZACITIDINE 3
4 AZACITIDINE FOR 3
5 BLEOMYCIN 3
6 BLEOMYCIN SULFATE 3
7 BLINATUMOMAB 3
8 CYTARABINE 3
9 DASATINIB 3
See all common drugs associated with TUMOUR CELL MOBILISATION

TUMOUR CELL MOBILISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DUVELISIB 3 0.0035
1 DECITABINE 3 0.0007
2 PONATINIB HYDROCHLORIDE 3 0.0006
3 DASATINIB 3 0.0003
4 BLEOMYCIN SULFATE 3 0.0003
5 BLINATUMOMAB 3 0.0003
6 SIROLIMUS 3 0.0002
7 MELPHALAN HYDROCHLORIDE 3 0.0001
8 NILOTINIB 3 0.0001
9 AZACITIDINE 3 0.0001
See all drugs enriched for association with TUMOUR CELL MOBILISATION